Lv13
30 积分 2025-06-04 加入
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
1天前
待确认
The innate immune landscape of dMMR/MSI cancers predicts outcome of nivolumab treatment: results from the Drug Rediscovery Protocol
1天前
已完结
RAD51 Expression as a Biomarker to Predict Efficacy of Platinum-Based Chemotherapy and PD-L1 Blockade for Muscle-Invasive Bladder Cancer
1天前
已完结
The prognostic impact of tumor deposits in colorectal cancer: More than just N1c
1天前
已完结
皖公网安备34019202002308
